Isradipine
- Product NDC
- 42806-263
- 11-digit product format
- 428060263
- Labeler code
- 42806
- Product ID
- 42806-263_2495a640-8be1-4b9f-891e-8fc9fd5a2b48
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Isradipine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Epic Pharma, LLC
- Application
- ANDA077169
- Marketing category
- ANDA
- Marketing start
- 2021-03-15
- Marketing end
- 0000-00-00
- Substance
- ISRADIPINE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42806-263-01 | 42806026301 | 100 CAPSULE in 1 BOTTLE (42806-263-01) | 100 capsule | 2014-05-15 | 0000-00-00 | No | No | Current |
| 42806-263-05 | 42806026305 | 500 CAPSULE in 1 BOTTLE (42806-263-05) | 500 capsule | 2014-05-15 | 0000-00-00 | No | No | Current |